These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 7471495)

  • 1. On the validity of a levo-norgestrel radioimmunoassay.
    Kanluan T; Masironi B; Cekan SZ
    Clin Chim Acta; 1981 Jan; 109(2):169-74. PubMed ID: 7471495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women.
    Nilsson S; Nygren KG; Johansson ED
    Am J Obstet Gynecol; 1977 Sep; 129(2):178-84. PubMed ID: 900181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive direct radioimmunoassay for assessing D-norgestrel levels in human plasma.
    Watson TG; Stewart BJ
    Ann Clin Biochem; 1988 May; 25 ( Pt 3)():280-7. PubMed ID: 3400986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of radioimmunoassay for estradiol-17 beta by isotope dilution-mass spectrometry and by a test of radiochemical purity.
    Xing S; Cekan SZ; Diczfalusy U; Falk O; Gustafsson SA; Akerlöf E; Björkhem I
    Clin Chim Acta; 1983 Dec; 135(2):189-201. PubMed ID: 6360429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of true values in radioimmunoassays.
    Riesco OF; Hajri-Mezghani S; Cekan SZ
    Clin Chem; 1989 Aug; 35(8):1680-3. PubMed ID: 2758636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of antisera, purification procedures, and tracers on validity of a testosterone radioimmunoassay.
    de Gomez MS; Frei A; Vitins P; Cekan SZ
    Ann Clin Biochem; 1981 Sep; 18(Pt 5):281-6. PubMed ID: 7305257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and use of a radioimmunoassay for D-(-)-norgestrel 17 beta-cyclopentanecarboxylate.
    Blye RP; Kim HK; Lindberg MC; Mitra SB; Naqvi RH; Peterson DM; Rao PN
    Steroids; 1986; 48(1-2):27-45. PubMed ID: 3660438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodine labelled ligands in the radioimmunoassay of synthetic progestins.
    Warren RJ; Fotherby K
    J Steroid Biochem; 1975 Jul; 6(7):1151-5. PubMed ID: 1177443
    [No Abstract]   [Full Text] [Related]  

  • 9. Test of radioimmunoassay validity in the presence of an isotope effect.
    Xing S; Zheng S; Cekan SZ
    Clin Chem; 1981 Apr; 27(4):600-2. PubMed ID: 7471427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of D- and L-norgestrel in humans.
    Warren RJ; Fotherby K
    Arzneimittelforschung; 1975 Jun; 25(6):964-5. PubMed ID: 169856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems of validity in steroid immunoassays.
    Cekan SZ
    J Steroid Biochem; 1983 Jul; 19(1B):403-5. PubMed ID: 6350718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Radioimmunoassay of synthetic progestins in plasma.
    Warren RJ; Fotherby K
    J Endocrinol; 1974 May; 61(2):XXXIX. PubMed ID: 4857740
    [No Abstract]   [Full Text] [Related]  

  • 13. The presence of dl-, d- and l-norgestrel and their metabolites in the plasma of women.
    Sisenwine SF; Kimmel HB; Liu AL; Ruelius HW
    Contraception; 1975 Sep; 12(3):339-53. PubMed ID: 1164851
    [No Abstract]   [Full Text] [Related]  

  • 14. Radioimmunoassay of progesterone in saliva.
    Sorgo W; Manella B; Zachmann M
    Horm Res; 1983; 17(3):153-9. PubMed ID: 6852777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple, rapid and sensitive UFLC-MS/MS method for the quantification of oral contraceptive norgestrel in human plasma and its pharmacokinetic applications.
    Batta N; Pigili RK; Pallapothu LM; Yejella RP
    Drug Res (Stuttg); 2014 Sep; 64(9):462-9. PubMed ID: 24310360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inter- and intra-individual variability of pharmacokinetic parameters for contraceptive steroids].
    Carol W; Klinger G; Jäger R; Kasch R; Michels W
    Zentralbl Gynakol; 1991; 113(13):783-7. PubMed ID: 1927130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the assessment of validity of steroid radioimmunoassays.
    Cekan SZ
    J Steroid Biochem; 1979; 11(5-6):1629-34. PubMed ID: 522478
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices.
    Perino A; Quartararo P; Catinella E; Genova G; Cittadini E
    Acta Eur Fertil; 1987; 18(2):137-40. PubMed ID: 3115027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of diatomite microcolumns for the chromatographic separation of steroids prior to radioimmunoassay.
    Abraham GE
    Pathol Biol (Paris); 1975 Dec; 23(10):889-93. PubMed ID: 772538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.